Ploidy reductions in murine fusion-derived hepatocytes

Andrew W. Duncan, Raymond D. Hickey, Nicole K. Paulk, Andrew J. Culberson, Susan Olson, Milton J. Finegold, Markus Grompe

Research output: Contribution to journalArticle

67 Citations (Scopus)

Abstract

We previously showed that fusion between hepatocytes lacking a crucial liver enzyme, fumarylacetoacetate hydrolase (FAH), and wild-type blood cells resulted in hepatocyte reprogramming. FAH expression was restored in hybrid hepatocytes and, upon in vivo expansion, ameliorated the effects of FAH deficiency. Here, we show that fusion-derived polyploid hepatocytes can undergo ploidy reductions to generate daughter cells with one-half chromosomal content. Fusion hybrids are, by definition, at least tetraploid. We demonstrate reduction to diploid chromosome content by multiple methods. First, cytogenetic analysis of fusion-derived hepatocytes reveals a population of diploid cells. Secondly, we demonstrate marker segregation using β-galactosidase and the Y-chromosome. Approximately 2-5% of fusion-derived FAH-positive nodules were negative for one or more markers, as expected during ploidy reduction. Next, using a reporter system in which β-galactosidase is expressed exclusively in fusion-derived hepatocytes, we identify a subpopulation of diploid cells expressing β-galactosidase and FAH. Finally, we track marker segregation specifically in fusion-derived hepatocytes with diploid DNA content. Hemizygous markers were lost by ≥50% of Fah-positive cells. Since fusion-derived hepatocytes are minimally tetraploid, the existence of diploid hepatocytes demonstrates that fusion-derived cells can undergo ploidy reduction. Moreover, the high degree of marker loss in diploid daughter cells suggests that chromosomes/markers are lost in a nonrandom fashion. Thus, we propose that ploidy reductions lead to the generation of genetically diverse daughter cells with about 50% reduction in nuclear content. The generation of such daughter cells increases liver diversity, which may increase the likelihood of oncogenesis.

Original languageEnglish (US)
Article numbere1000385
JournalPLoS Genetics
Volume5
Issue number2
DOIs
StatePublished - Feb 2009

Fingerprint

ploidy
Ploidies
hepatocytes
Hepatocytes
Diploidy
hydrolases
mice
diploidy
Galactosidases
galactosidases
chromosome
cells
Tetraploidy
tetraploidy
cytogenetics
subpopulation
chromosomes
marker
liver
Polyploidy

ASJC Scopus subject areas

  • Genetics
  • Molecular Biology
  • Ecology, Evolution, Behavior and Systematics
  • Cancer Research
  • Genetics(clinical)

Cite this

Duncan, A. W., Hickey, R. D., Paulk, N. K., Culberson, A. J., Olson, S., Finegold, M. J., & Grompe, M. (2009). Ploidy reductions in murine fusion-derived hepatocytes. PLoS Genetics, 5(2), [e1000385]. https://doi.org/10.1371/journal.pgen.1000385

Ploidy reductions in murine fusion-derived hepatocytes. / Duncan, Andrew W.; Hickey, Raymond D.; Paulk, Nicole K.; Culberson, Andrew J.; Olson, Susan; Finegold, Milton J.; Grompe, Markus.

In: PLoS Genetics, Vol. 5, No. 2, e1000385, 02.2009.

Research output: Contribution to journalArticle

Duncan, AW, Hickey, RD, Paulk, NK, Culberson, AJ, Olson, S, Finegold, MJ & Grompe, M 2009, 'Ploidy reductions in murine fusion-derived hepatocytes', PLoS Genetics, vol. 5, no. 2, e1000385. https://doi.org/10.1371/journal.pgen.1000385
Duncan AW, Hickey RD, Paulk NK, Culberson AJ, Olson S, Finegold MJ et al. Ploidy reductions in murine fusion-derived hepatocytes. PLoS Genetics. 2009 Feb;5(2). e1000385. https://doi.org/10.1371/journal.pgen.1000385
Duncan, Andrew W. ; Hickey, Raymond D. ; Paulk, Nicole K. ; Culberson, Andrew J. ; Olson, Susan ; Finegold, Milton J. ; Grompe, Markus. / Ploidy reductions in murine fusion-derived hepatocytes. In: PLoS Genetics. 2009 ; Vol. 5, No. 2.
@article{f04df8f9294242d28f7be74742cc4d60,
title = "Ploidy reductions in murine fusion-derived hepatocytes",
abstract = "We previously showed that fusion between hepatocytes lacking a crucial liver enzyme, fumarylacetoacetate hydrolase (FAH), and wild-type blood cells resulted in hepatocyte reprogramming. FAH expression was restored in hybrid hepatocytes and, upon in vivo expansion, ameliorated the effects of FAH deficiency. Here, we show that fusion-derived polyploid hepatocytes can undergo ploidy reductions to generate daughter cells with one-half chromosomal content. Fusion hybrids are, by definition, at least tetraploid. We demonstrate reduction to diploid chromosome content by multiple methods. First, cytogenetic analysis of fusion-derived hepatocytes reveals a population of diploid cells. Secondly, we demonstrate marker segregation using β-galactosidase and the Y-chromosome. Approximately 2-5{\%} of fusion-derived FAH-positive nodules were negative for one or more markers, as expected during ploidy reduction. Next, using a reporter system in which β-galactosidase is expressed exclusively in fusion-derived hepatocytes, we identify a subpopulation of diploid cells expressing β-galactosidase and FAH. Finally, we track marker segregation specifically in fusion-derived hepatocytes with diploid DNA content. Hemizygous markers were lost by ≥50{\%} of Fah-positive cells. Since fusion-derived hepatocytes are minimally tetraploid, the existence of diploid hepatocytes demonstrates that fusion-derived cells can undergo ploidy reduction. Moreover, the high degree of marker loss in diploid daughter cells suggests that chromosomes/markers are lost in a nonrandom fashion. Thus, we propose that ploidy reductions lead to the generation of genetically diverse daughter cells with about 50{\%} reduction in nuclear content. The generation of such daughter cells increases liver diversity, which may increase the likelihood of oncogenesis.",
author = "Duncan, {Andrew W.} and Hickey, {Raymond D.} and Paulk, {Nicole K.} and Culberson, {Andrew J.} and Susan Olson and Finegold, {Milton J.} and Markus Grompe",
year = "2009",
month = "2",
doi = "10.1371/journal.pgen.1000385",
language = "English (US)",
volume = "5",
journal = "PLoS Genetics",
issn = "1553-7390",
publisher = "Public Library of Science",
number = "2",

}

TY - JOUR

T1 - Ploidy reductions in murine fusion-derived hepatocytes

AU - Duncan, Andrew W.

AU - Hickey, Raymond D.

AU - Paulk, Nicole K.

AU - Culberson, Andrew J.

AU - Olson, Susan

AU - Finegold, Milton J.

AU - Grompe, Markus

PY - 2009/2

Y1 - 2009/2

N2 - We previously showed that fusion between hepatocytes lacking a crucial liver enzyme, fumarylacetoacetate hydrolase (FAH), and wild-type blood cells resulted in hepatocyte reprogramming. FAH expression was restored in hybrid hepatocytes and, upon in vivo expansion, ameliorated the effects of FAH deficiency. Here, we show that fusion-derived polyploid hepatocytes can undergo ploidy reductions to generate daughter cells with one-half chromosomal content. Fusion hybrids are, by definition, at least tetraploid. We demonstrate reduction to diploid chromosome content by multiple methods. First, cytogenetic analysis of fusion-derived hepatocytes reveals a population of diploid cells. Secondly, we demonstrate marker segregation using β-galactosidase and the Y-chromosome. Approximately 2-5% of fusion-derived FAH-positive nodules were negative for one or more markers, as expected during ploidy reduction. Next, using a reporter system in which β-galactosidase is expressed exclusively in fusion-derived hepatocytes, we identify a subpopulation of diploid cells expressing β-galactosidase and FAH. Finally, we track marker segregation specifically in fusion-derived hepatocytes with diploid DNA content. Hemizygous markers were lost by ≥50% of Fah-positive cells. Since fusion-derived hepatocytes are minimally tetraploid, the existence of diploid hepatocytes demonstrates that fusion-derived cells can undergo ploidy reduction. Moreover, the high degree of marker loss in diploid daughter cells suggests that chromosomes/markers are lost in a nonrandom fashion. Thus, we propose that ploidy reductions lead to the generation of genetically diverse daughter cells with about 50% reduction in nuclear content. The generation of such daughter cells increases liver diversity, which may increase the likelihood of oncogenesis.

AB - We previously showed that fusion between hepatocytes lacking a crucial liver enzyme, fumarylacetoacetate hydrolase (FAH), and wild-type blood cells resulted in hepatocyte reprogramming. FAH expression was restored in hybrid hepatocytes and, upon in vivo expansion, ameliorated the effects of FAH deficiency. Here, we show that fusion-derived polyploid hepatocytes can undergo ploidy reductions to generate daughter cells with one-half chromosomal content. Fusion hybrids are, by definition, at least tetraploid. We demonstrate reduction to diploid chromosome content by multiple methods. First, cytogenetic analysis of fusion-derived hepatocytes reveals a population of diploid cells. Secondly, we demonstrate marker segregation using β-galactosidase and the Y-chromosome. Approximately 2-5% of fusion-derived FAH-positive nodules were negative for one or more markers, as expected during ploidy reduction. Next, using a reporter system in which β-galactosidase is expressed exclusively in fusion-derived hepatocytes, we identify a subpopulation of diploid cells expressing β-galactosidase and FAH. Finally, we track marker segregation specifically in fusion-derived hepatocytes with diploid DNA content. Hemizygous markers were lost by ≥50% of Fah-positive cells. Since fusion-derived hepatocytes are minimally tetraploid, the existence of diploid hepatocytes demonstrates that fusion-derived cells can undergo ploidy reduction. Moreover, the high degree of marker loss in diploid daughter cells suggests that chromosomes/markers are lost in a nonrandom fashion. Thus, we propose that ploidy reductions lead to the generation of genetically diverse daughter cells with about 50% reduction in nuclear content. The generation of such daughter cells increases liver diversity, which may increase the likelihood of oncogenesis.

UR - http://www.scopus.com/inward/record.url?scp=61449093808&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=61449093808&partnerID=8YFLogxK

U2 - 10.1371/journal.pgen.1000385

DO - 10.1371/journal.pgen.1000385

M3 - Article

C2 - 19229314

AN - SCOPUS:61449093808

VL - 5

JO - PLoS Genetics

JF - PLoS Genetics

SN - 1553-7390

IS - 2

M1 - e1000385

ER -